USPTO serial 79439722
LYVANTA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SEVERSON, JUSTIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with LYVANTA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas R. Wolf
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Fertility-enhancing drugs; pharmaceuticals and medical preparations, namely, fertility-enhancing drugs, ovulation stimulants, and hormonal therapies for stimulating ovulation to aid in conception; pharmaceutical and medical preparations for fertility treatments, namely, fertility-enhancing drugs, ovulation stimulants, and hormonal therapies for stimulating ovulation to aid in conception; ovulation stimulants, namely, pharmaceutical preparations for stimulating ovulation; pharmaceutical drugs that stimulate ovulation to aid in conception; dietary supplements for reproductive health; diagnostic reagents for medical use; dietary supplements to support implantation of embryos; hormonal therapies being pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and support of hormonal disorders; In vitro fertilization (IVF) diagnostic preparations for medical purposes; cell cryopreservation solutions for medical purposes, namely, solutions for medical and clinical use in storing and treating cells, blood, and blood components; semen analysis kits comprised of semen analyzing devices for medical purposes; endometrial receptivity tests for medical purposes; luteal phase support in the form of dietary supplements; tests to measure ovarian reserve and predict response to fertility treatments for medical use; tests to evaluate ovarian function and fertility potential for medical use; nutrient solutions for medical and clinical use to support the growth of embryos in the lab | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 6, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 1, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 30, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 16, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 16, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 4, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 26, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 26, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 27, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 27, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 27, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 9, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 9, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 21, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 1, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 1, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 24, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 29, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 29, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 18, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |